Signs Of R&D Progress For GSK, Though China Overhang Remains

 
• By Jessica Merrill and Daniel Poppy
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia